Allstate Corp Jazz Pharmaceuticals PLC Transaction History

Allstate Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$95.68 - $121.88 $211,931 - $269,964	-2,215 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$87.74 - $152.74 $842,830 - $1.47 Million	-9,606 Reduced 81.26%	2,215 $221,000
Q4 2019 Feb 14, 2020	SELL	$117.65 - $153.73 $42,706 - $55,803	-363 Reduced 2.98%	11,821 $1.77 Million
Q3 2019 Nov 14, 2019	BUY	$125.18 - $143.24 $405,207 - $463,667	3,237 Added 36.18%	12,184 $1.56 Million
Q2 2019 Aug 14, 2019	BUY	$125.55 - $144.48 $1.12 Million - $1.29 Million	8,947 New	8,947 $1.28 Million

Q1 2019 May 20, 2019	SELL	$121.81 - $142.95 $471,161 - $552,930	-3,868 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$115.94 - $166.74 $448,455 - $644,950	3,868 New	3,868 $479,000

515

57M

65.9K

183K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $6.31B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

Stay updated on Allstate Corp with notifications on news.